Bloomsbury Publishing Plc (LON:BMY – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 670.97 ($8.47) and traded as low as GBX 667.61 ($8.43). Bloomsbury Publishing shares last traded at GBX 698 ($8.81), with a volume of 110,872 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank started coverage on shares of Bloomsbury Publishing in a report on Wednesday, November 6th. They issued a “buy” rating and a GBX 825 ($10.41) price target on the stock.
View Our Latest Analysis on Bloomsbury Publishing
Bloomsbury Publishing Price Performance
Bloomsbury Publishing Cuts Dividend
The business also recently declared a dividend, which was paid on Friday, November 29th. Investors of record on Thursday, October 31st were issued a GBX 3.89 ($0.05) dividend. This represents a yield of 0.57%. The ex-dividend date was Thursday, October 31st. Bloomsbury Publishing’s dividend payout ratio (DPR) is currently 3,846.15%.
Insider Buying and Selling at Bloomsbury Publishing
In other news, insider Leslie-Ann Reed purchased 12,139 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was bought at an average cost of GBX 659 ($8.32) per share, with a total value of £79,996.01 ($100,966.82). Insiders own 8.26% of the company’s stock.
About Bloomsbury Publishing
Bloomsbury Publishing Plc publishes academic, educational, and general fiction and non-fiction books for children, teachers, students, researchers, and professionals worldwide. The company offers books and digital resources to international research community and higher education students; online law, accounting, and tax services for the United Kingdom and professionals; and publishing services for corporations and institutions.
Further Reading
- Five stocks we like better than Bloomsbury Publishing
- Top Stocks Investing in 5G Technology
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Are Penny Stocks a Good Fit for Your Portfolio?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Buy P&G Now, Before It Sets A New All-Time High
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Bloomsbury Publishing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bloomsbury Publishing and related companies with MarketBeat.com's FREE daily email newsletter.